• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Stepping into the Spotlight for 2021

    The Independent Beauty Association Supports Sensible Reform

    Essential Workers

    A Clean Commitment

    Deliver & Delight
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    Amyris Named a Top Social & Environmental Impact Company

    L'Oréal Bans Animal Hair in Brushes

    Ashland Launches Antaron ECo Gel

    Isosorbide Di-(Linoleate/Oleate) Treats Xerotic Pruritic Skin

    Estée Lauder Appoints SVP, New Business Development
    Blog
    Online Exclusives
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    HappiTV
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    3. Reckitt Benckiser

    40. Perfumania Holdings Inc.

    13. GlaxoSmithKline

    3. Henkel

    1. Procter & Gamble
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    Amyris Named a Top Social & Environmental Impact Company

    Coming Clean About Clean Beauty

    Isosorbide Di-(Linoleate/Oleate) Treats Xerotic Pruritic Skin

    Nu Skin Launches ‘Clean’ Formula Line

    HydraFacial Adds Murad Booster
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    Amyris Named a Top Social & Environmental Impact Company

    L'Oréal Bans Animal Hair in Brushes

    Coming Clean About Clean Beauty

    Ashland Launches Antaron ECo Gel

    Isosorbide Di-(Linoleate/Oleate) Treats Xerotic Pruritic Skin
    Lab Equipment
    Mixing
    Packaging
    Testing

    Logo Design Trends for 2021 & Beyond

    Coming Clean About Stink

    Henkel Reaches Sustainable Packaging Milestone

    Ross Designs Mixer for Increased Shear

    CGF Coalition Finalizes 'Golden Design' Rules
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Vantage Specialty Ingredients

    Croda

    QRS (Quality Resourcing Services)

    Centerchem Inc

    Sabinsa Cosmetics, a division of Sabinsa Corporation
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Experts Opinion
    • Slideshows
    • HappiTV
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Issues Letter to Soleo of Korea

    Agency outlines issues with drug claims and more.

    Related CONTENT
    • ACI Approves FDA Proposal for Food Handler Antiseptics
    • Hemp Declassification To Light Up CBD Market
    • Prospects for Cosmeceuticals Dim in China
    • FDA Issues RFI on Food Handler Antiseptics
    • ACI Welcomes New FDA Rulemaking for Food Handler Antiseptics
    02.06.19
     The US Food and Drug Administration (FDA) has sent a warning letter to Ji Hyun Min, CEO of Soleo of Korea. FDA conducted an inspection of the company’s drug manufacturing facility from August 6 to 9, 2018. The warning letter summarizes significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. See 21 CFR, parts 210 and 211.
     
    Because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, your drug products are adulterated within the meaning of section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 351(a)(2)(B)).
     
    In addition, as formulated and labeled, “Gen+Le Therapy Shampoo” is an unapproved new drug in violation of section 505(a) of the FD&C Act (21 U.S.C. 355(a)). Introduction of such a product into interstate commerce is prohibited under section 301(d) of the FD&C Act (21 U.S.C. 331(d)).
     
    During the inspection, the FDA investigator observed specific violations.

    For example, Sole failed to conduct at least one test to verify the identity of each component of a drug product. Your firm also failed to validate and establish the reliability of your component supplier’s test analyses at appropriate intervals (21 CFR 211.84(d)(1) and (2)).
     
    According to FDA, the company lacked testing of incoming raw materials, including active pharmaceutical ingredients and components, used in manufacturing of your Gentle Therapy Shampoo over-the-counter (OTC) drug product, for their identity, strength, and other appropriate quality attributes. Instead, your firm relied solely on your suppliers’ certificates of analysis (COA) without establishing the reliability of the suppliers’ analyses through appropriate validation.
     
    FDA said it reviewed the company’s August 23, 2018 response in detail, in which Soleo said it would “ try to proceed by purchasing the experimental equipment also so that we [Soleo] can directly analyze the ingredients contained in the raw material”.
     
    FDA called the company’s response inadequate because it failed to provide a detailed procedure for conducting raw material testing, a target date for implementation, and a plan of action in the interim.
     
    In response to this letter, FDA has asked the company to provide:

    • Chemical and microbiological quality control specifications you will use to approve the release of each incoming lot of components for use in manufacturing.
    • A description of how you will conduct at least one specific identity test for each incoming component lot, regardless of a COA validation program
    • A description of how you will test each component lot for conformity with all appropriate specifications for strength, quality, and purity. If you intend to accept any testing results from your supplier’s COA in lieu of your testing of each component lot for purity, strength, and quality, specify how you plan to establish the reliability and consistency of your supplier’s test results for these attributes through initial validation (followed by periodic re-validation). Include your standard operating procedure that describes this COA validation program.

    A summary of test results obtained from full testing of reserves samples of active pharmaceutical ingredient lots used in the manufacture of your drug product that were distributed to the U.S. market and within expiry.

    • A comprehensive independent review of your material system to determine whether all containers, closures, and ingredients from each supplier are adequately qualified and are assigned appropriate expiration or retest dates. Also determine whether your controls for incoming material lots are adequate to prevent the use of unsuitable containers, closures, and components.
     
    FDA said Soleo failed to establish and document the accuracy, sensitivity, specificity, and reproducibility of its test methods (21 CFR 211.165(e)).
     
    FDA also said Soleo failed to establish written procedures for production and process control designed to assure that the drug products you manufacture have the identity, strength, quality, and purity they purport or are represented to possess (21 CFR 211.100(a)).
     
    FDA also contends Soleo failed to establish and follow an adequate written testing program designed to assess the stability characteristics of drug products and to use results of stability testing to determine appropriate storage conditions and expiration dates (21 CFR 211.166(a)).
     
    Based upon the nature of the violations identified, FDA said it strongly recommends engaging a consultant, qualified as set forth in 21 CFR 211.34, to evaluate your operations and assist your firm in meeting CGMP requirements. “We also recommend that the qualified consultant perform a comprehensive audit of your entire operation for CGMP compliance and evaluate the completion and effectiveness of any corrective action and preventative action plan you have implemented,” FDA penned in its letter.
     
    Examples of claims observed on Soleo’s product label, and on its labeling which includes your product website for “GEN+LE THERAPY Shampoo” that establish the intended uses of the product as defined in 21 CFR 201.128 include, but may not be limited to, the following:
    ·       Label Claims:
    “Prevents Hair Loss ... Hair Loss Prevention ... Anti-Dandruff”
    ·       Website Claims:
    “Is your dandruff out of control? The solution is GEN+LE THERAPY SHAMPOO & TREATEMENT ... Anti-Dandruff ... A inveterate Dandruff goes away in a short time ... Hair Loss Prevention ... Biotin helps your hair grow ...”
     
    Based on the above claims, “GEN+LE THERAPY Shampoo” is a “drug” as defined by section 201(g)(1)(B) of the FD&C Act (21 U.S.C. 321(g)(1)(B)) because it is intended for the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or under section 201(g)(1)(C) of the FD&C Act (21 U.S.C. 321(g)(1)(C)) because it is intended to affect the structure or any function of the body. Specifically, this product is intended as a hair growth, hair loss prevention, and anti-dandruff drug product. 
     
    Under 21 CFR 310.527, OTC drug products intended as an external hair grower, such as “GEN+LE THERAPY Shampoo”, that are labeled, represented, or promoted for external use as a hair grower or for hair loss prevention are regarded as new drugs within the meaning of section 201(p) of the FD&C Act and require an FDA-approved application prior to being marketed.
     
    In addition, drug products intended for the treatment of dandruff, such as “GEN+LE THERAPY Shampoo” are subject to the Final Rule for Drug Products for the Control of Dandruff, Seborrheic Dermatitis, and Psoriasis (21 CFR 358, Subpart H). However, the formulation for “GEN+LE THERAPY Shampoo” is not consistent with the formulation requirements that describe acceptable active ingredients for drug products for the treatment of dandruff. Specifically, biotin, niacinamide, and dexpanthenol do not comply with the acceptable active ingredients in 21 CFR 358.710.
     
    Thus, as formulated and labeled, “GEN+LE THERAPY Shampoo” does not comply with the final rules described above. Furthermore, we are not aware of sufficient evidence to show that “GEN+LE THERAPY Shampoo”, as formulated and labeled, is generally recognized as safe and effective. Therefore, this product is a new drug within the meaning of section 201(p) of the FD&C Act (21 U.S.C. 321(p)). As a new drug, “GEN+LE THERAPY Shampoo” may not be legally marketed in the United States absent approval of an application filed in accordance with section 505(a) of the FD&C Act (21 U.S.C. 355(a)). “GEN+LE THERAPY Shampoo” is not the subject of an FDA-approved application and therefore, the current marketing of this product violates section 505(a) of the FD&C Act (21 U.S.C. 355(a)). Introduction of such products into interstate commerce is prohibited under section 301(d) of the FD&C Act (21 U.S.C. 331(d)).
     
    FDA placed the firm on Import Alert 66-40 on November 26, 2018, and indicated that until Soelo corrects all violations completely and FDA confirms compliance with CGMP, it may withhold approval of any new applications or supplements listing your firm as a drug manufacturer.
     
    Failure to correct these violations may also result in FDA continuing to refuse admission of articles manufactured at Soleo at 24 Sandan-Ro, Pyeongtaek-Si, Gyeonggi-do, into the United States under section 801(a)(3) of the FD&C Act (21 U.S.C. 381(a)(3)). Under the same authority, articles may be subject to refusal of admission, in that the methods and controls used in their manufacture do not appear to conform to CGMP within the meaning of section 501(a)(2)(B) of the FD&C Act (21 U.S.C. 351(a)(2)(B)), said FDA.
    Related Searches
    • marketing
    • hair
    • treatment
    • and cosmetic act
    Related Knowledge Center
    • Hair Care
    Suggested For You
    ACI Approves FDA Proposal for Food Handler Antiseptics ACI Approves FDA Proposal for Food Handler Antiseptics
    Hemp Declassification To Light Up CBD Market Hemp Declassification To Light Up CBD Market
    Prospects for Cosmeceuticals Dim in China Prospects for Cosmeceuticals Dim in China
    FDA Issues RFI on Food Handler Antiseptics FDA Issues RFI on Food Handler Antiseptics
    ACI Welcomes New FDA Rulemaking for Food Handler Antiseptics ACI Welcomes New FDA Rulemaking for Food Handler Antiseptics
    FDA Issues RFI on OTC Food Handler Antiseptics FDA Issues RFI on OTC Food Handler Antiseptics
    Surf’s Up: Hawaii Makes Waves with Ban of Sunscreen Filters Surf’s Up: Hawaii Makes Waves with Ban of Sunscreen Filters
    Demand for Acne Treatment Rises Demand for Acne Treatment Rises
    FDA Seeks Comments on Proposed Consumer Survey about Allergens in Cosmetics FDA Seeks Comments on Proposed Consumer Survey about Allergens in Cosmetics
    Verify then Trust Verify then Trust
    Tennessee Skin/Haircare Company Ordered To Halt Operations Tennessee Skin/Haircare Company Ordered To Halt Operations
    Cap It Off! Cap It Off!
    Where Cosmetics & Pharma Meet Where Cosmetics & Pharma Meet
    OTC Sunscreen Filters Are on Life Support OTC Sunscreen Filters Are on Life Support
    Testing, Testing Testing, Testing

    Related Breaking News

    • Color Cosmetics | Hair Care
      L

      L'Oréal Bans Animal Hair in Brushes

      Joins nearly 100 companies in eliminating badger and goat hair.
      Happi Staff 01.15.21

    • Color Cosmetics | Hair Care | Skin Care
      L

      L'Oréal Names Chief Communications Officer

      Bianca Juti to join executive committee in April.
      Happi Staff 01.13.21

    • Hair Care | Skin Care
      New CEO for Dollar Shave Club

      New CEO for Dollar Shave Club

      Founder Michael Dubin will step down this month.
      Happi Staff 01.12.21


    • Hair Care
      Amyris Partners with Jonathan Van Ness

      Amyris Partners with Jonathan Van Ness

      Plans to launch a clean inclusive haircare brand during the summer of 2021.
      Happi Staff 01.11.21

    • Hair Care
      Mast Hair Launches Grooming Essentials

      Mast Hair Launches Grooming Essentials

      Introduces cruelty-free hair care products with biodegradable packaging.
      Happi Staff 01.11.21

    • Color Cosmetics | Hair Care
      Sustainability Push from L

      Sustainability Push from L'Oréal at CES

      Water-saving technology in the salon and on-demand YSL lip color.
      Happi Staff 01.11.21


    • Color Cosmetics | Hair Care
      Brite Debuts Hair Color at Target

      Brite Debuts Hair Color at Target

      Debuts a line of plant-based hair dyes.
      Happi Staff 01.11.21

    • Color Cosmetics | Hair Care | Laundry Care | Skin Care
      What You

      What You're Reading on Happi.com

      Procter & Gamble dominates the news for the week ended January 9.
      Happi Staff 01.10.21

    • Hair Care
      Curlsmith Closes Series A Funding

      Curlsmith Closes Series A Funding

      Continues its expansion in the US and Europe.
      Happi Staff 01.08.21


    • Hair Care
      Splat Adds First Permanent Color

      Splat Adds First Permanent Color

      Double Lift is a bleach-free formula specifically designed for dark hair.
      Happi Staff 01.08.21

    • Hair Care | Skin Care
      New Inner Beauty Launches

      New Inner Beauty Launches

      Is the focus on wellness creating new opportunities for ingestible beauty products?
      Happi Staff 01.08.21

    • Hair Care
      Waterless Shampoos & Conditioners Arrive from Everist

      Waterless Shampoos & Conditioners Arrive from Everist

      Female-founded clean beauty company debuts in U.S. and Canada.
      Happi Staff 01.08.21


    • Color Cosmetics | Hair Care | I&I Marketplace | Packaging | Skin Care | Testing
      Trade Shows Will be Back in 2021

      Trade Shows Will be Back in 2021

      Informa is optimistic as COVID-19 vaccine rolls out around the world.
      Happi Staff 01.06.21

    • Hair Care | Preservatives

      Unilever Sued Over Tresemmé

      Plaintiffs claim DMDM hydantoin puts consumers at risk.
      Happi Staff 01.03.21

    • Actives | Color Cosmetics | Functional Ingredients | Hair Care | Skin Care
      What You’re Reading on Happi.com

      What You’re Reading on Happi.com

      Millie Bobby Brown’s acquisition tops our list for the week ended Jan. 2, 2021.
      Happi Staff 01.03.21

    Trending
    • Amyris Named A Top Social & Environmental Impact Company
    • Formulating Liquid Laundry Detergents
    • Reusables For Consumables In The Pandemic And Beyond
    • Maybelline Unveils 'Sky High' Mascara
    • Croda Partners With Genesis Biosciences
    Breaking News
    • Amyris Named a Top Social & Environmental Impact Company
    • L'Oréal Bans Animal Hair in Brushes
    • Ashland Launches Antaron ECo Gel
    • Isosorbide Di-(Linoleate/Oleate) Treats Xerotic Pruritic Skin
    • Estée Lauder Appoints SVP, New Business Development
    View Breaking News >
    CURRENT ISSUE

    January 2021

    • Stepping into the Spotlight for 2021
    • The Independent Beauty Association Supports Sensible Reform
    • Essential Workers
    • A Clean Commitment
    • Deliver & Delight
    • Reusables for Consumables In the Pandemic and Beyond
    • A Rebound for Beauty
    • Beauty Brands Must Prepare for a 'Decade of the Home'
    • A Societal Shift
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    What You're Reading on Happi.com
    Amyris Named a Top Social & Environmental Impact Company
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login